Literature DB >> 11084059

Acute rejection of hepatic allografts from HLA-DR13 (Allele DRB1(*)1301)-positive donors.

M Oertel1, F Berr, S Schröder, R Schwarz, A Tannapfel, M Wenzke, P Lamesch, J Hauss, K Kohlhaw.   

Abstract

Acute rejection of hepatic allografts does not show consistent association with the number of mismatches of HLA classes I and II. Therefore, we investigated the relation between specific donor or recipient HLA antigens and the occurrence of acute rejection. HLA typing of 35 liver transplant recipients and donors was performed by serological standard technique, with confirmation and subtyping by polymerase chain reaction with sequence-specific primers. HLA class I antigens were not associated with the occurrence of acute rejection. The graft was positive for HLA-DR13 in 8 of 13 transplant recipients (62%) with acute rejection, but only 4 of 22 recipients (18%; P =.024; P(Bonferroni-corrected) =.33, not significant) without rejection. The graft was positive for DRB1*1301 in 7 of 13 recipients (54%) with acute rejection, but only 1 of 22 recipients (5%) without rejection (P =.002; P(Bonferroni-corrected )=.028). This patient had experienced long-lasting bacterial sepsis, which markedly reduced the risk for acute rejection. We speculate that the expression of donor DRB1*1301 (if mismatched) may increase the risk for acute hepatic allograft rejection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11084059     DOI: 10.1053/jlts.2000.18480

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  4 in total

1.  The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis.

Authors:  Yuval A Patel; Jacqueline B Henson; Julius M Wilder; Jiayin Zheng; Schein-Chung Chow; Carl L Berg; Stuart J Knechtle; Andrew J Muir
Journal:  Clin Transplant       Date:  2018-09-15       Impact factor: 2.863

Review 2.  Natural killer cells in rejection and tolerance of solid organ allografts.

Authors:  Gilles Benichou; Yohei Yamada; Akihiro Aoyama; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2011-02       Impact factor: 2.640

3.  Innate immunity and resistance to tolerogenesis in allotransplantation.

Authors:  Gilles Benichou; Makoto Tonsho; Georges Tocco; Ognjenka Nadazdin; Joren C Madsen
Journal:  Front Immunol       Date:  2012-04-19       Impact factor: 7.561

4.  HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity.

Authors:  Camilla Stephens; Miguel-Ángel López-Nevot; Francisco Ruiz-Cabello; Eugenia Ulzurrun; Germán Soriano; Manuel Romero-Gómez; Antonia Moreno-Casares; M Isabel Lucena; Raúl J Andrade
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.